The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacy

By sjmartinez • May 25, 2023

Minkis K, Bolotin D, Council ML, Bar A, Farah RS, Kibbi N, Miest RYN, Orringer JS, Ortiz A, Suozzi KC, Vashi NA, Yoo SS, Albrecht J, Blalock TW, Bruce AJ, Deng M, Desai S, Eshaq M, Fiessinger LA, Ghareeb E, Greywal T, Hebert AA, Hooper D, Hordinsky M, Hu JC, Jibbe A, Joo J, Kelly KM, Kenkare S, Khetarpal S, Kole LCS, Kourosh AS, Kuhn H, Lee KC, Lucas R, Luke J, Mafee M, Mayo TT, Nawas ZY, Olasz Harken EB, Pearlstein MV, Petronic-Rosic V, Robinson CA, Rogge MN, Sachs DL, Saikaly SK, Schenck OL, Schlick CA, Shahabi L, Shipp DM, Shive M, Silapunt S, Suggs AK, Tolaymat L, Ward KHM, Weinstein Velez M, Zeichner J, Kang BY, Ibrahim SA, Christensen RE, Anvery N, Dirr MA, Lawrence N, Alam M. The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacy. Arch Dermatol Res. 2023 Jul;315(5):1449-1452. doi: 10.1007/s00403-022-02489-y. Epub 2022 Dec 2. PMID: 36456760.

Tags: Dermatology, Publications

Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials

Lebwohl M, Warren RB, Sofen H, Imafuku S, Paul C, Szepietowski JC, Spelman L, Passeron T, Vritzali E, Napoli A, Kisa RM, Buck A, Banerjee[...]

Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials

Merola JF, Armstrong A, Khattri S, Paek SY, Padilla B, Yue C, Photowala H, Kaplan B, Kristensen LE. Efficacy of risankizumab across subgroups in patients[...]

An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis

Sadrolashrafi K, Guo L, Kikuchi R, Hao A, Yamamoto RK, Tolson HC, Bilimoria SN, Yee DK, Armstrong AW. An OX-Tra'Ordinary Tale: The Role of OX40[...]